| EMA number | EMEA/H/C/005826 |
| ATC code | H01CB02 |
| Authorisation | 2 December 2022 |
| Withdrawn | 26 February 2025 |
| Revision | - |
Mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.